One Genomics


Developer of genome-editing and AI-driven discovery capabilities focused on aging and genetic interventions. Combines iterative genome-editing optimization and a multi-agent LLM platform to generate and evaluate genetic variants and to improve editing precision and safety. Publishes research in peer-reviewed journals.

Industries

biopharma
biotechnology
health-care
information-technology-dbca

Nr. of Employees

small (1-50)

One Genomics

San Francisco, California, United States, North America


Products

Safeguard genome editing technology

A genome editing platform that allows fine tuning of editing activity to optimize precision, efficacy, and safety in gene editing applications.

Safeguard sgRNA

A technology that enhances the safety and precision of CRISPR gene editing by improving guide RNA design to reduce off-target effects and cellular toxicity.


Services

Genome-editing platform delivery

Provision of a fine-tunable genome-editing platform that supports optimization of editing parameters for precision and safety.

AI-driven discovery platform

LLM-powered, multi-agent software to automate design and evaluation cycles for genetic interventions and variant discovery.

Expertise Areas

  • Genome-editing platform development
  • AI-driven genetic discovery
  • CRISPR/Cas9 optimization and sgRNA engineering
  • Epigenetics and aging research
  • Show More (1)

Key Technologies

  • Genome editing (CRISPR/Cas9)
  • sgRNA engineering
  • LLM-driven multi-agent AI
  • Iterative experimental optimization
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.